BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24251972)

  • 1. Preparation and characterization of albumin conjugates of a truncated peptide YY analogue for half-life extension.
    Ehrlich GK; Michel H; Truitt T; Riboulet W; Pop-Damkov P; Goelzer P; Hainzl D; Qureshi F; Lueckel B; Danho W; Conde-Knape K; Konkar A
    Bioconjug Chem; 2013 Dec; 24(12):2015-24. PubMed ID: 24251972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible PEGylation of peptide YY3-36 prolongs its inhibition of food intake in mice.
    Shechter Y; Tsubery H; Mironchik M; Rubinstein M; Fridkin M
    FEBS Lett; 2005 Apr; 579(11):2439-44. PubMed ID: 15848185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of positions in the human neuropeptide Y/peptide YY receptor Y2 that contribute to pharmacological differences between receptor subtypes.
    Fällmar H; Åkerberg H; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D
    Neuropeptides; 2011 Aug; 45(4):293-300. PubMed ID: 21696823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel selective neuropeptide Y2 receptor PEGylated peptide agonists reduce food intake and body weight in mice.
    Lumb KJ; DeCarr LB; Milardo LF; Mays MR; Buckholz TM; Fisk SE; Pellegrino CM; Ortiz AA; Mahle CD
    J Med Chem; 2007 May; 50(9):2264-8. PubMed ID: 17425299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthogonal assembly of a designed ankyrin repeat protein-cytotoxin conjugate with a clickable serum albumin module for half-life extension.
    Simon M; Frey R; Zangemeister-Wittke U; Plückthun A
    Bioconjug Chem; 2013 Nov; 24(11):1955-66. PubMed ID: 24168270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenesis of human neuropeptide Y/peptide YY receptor Y2 reveals additional differences to Y1 in interactions with highly conserved ligand positions.
    Akerberg H; Fällmar H; Sjödin P; Boukharta L; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D
    Regul Pept; 2010 Aug; 163(1-3):120-9. PubMed ID: 20471432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-selective conjugation of an anticoagulant aptamer to recombinant albumins and maintenance of neonatal Fc receptor binding.
    Schmøkel J; Voldum A; Tsakiridou G; Kuhlmann M; Cameron J; Sørensen ES; Wengel J; Howard KA
    Nanotechnology; 2017 May; 28(20):204004. PubMed ID: 28362634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced extravasation, stability and in vivo cardiac gene silencing via in situ siRNA-albumin conjugation.
    Lau S; Graham B; Cao N; Boyd BJ; Pouton CW; White PJ
    Mol Pharm; 2012 Jan; 9(1):71-80. PubMed ID: 22141328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide.
    Neuner P; Peier AM; Talamo F; Ingallinella P; Lahm A; Barbato G; Di Marco A; Desai K; Zytko K; Qian Y; Du X; Ricci D; Monteagudo E; Laufer R; Pocai A; Bianchi E; Marsh DJ; Pessi A
    J Pept Sci; 2014 Jan; 20(1):7-19. PubMed ID: 24222478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
    Umeda T; Kanatani A; Iwaasa H
    Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents.
    Ortiz AA; Milardo LF; DeCarr LB; Buckholz TM; Mays MR; Claus TH; Livingston JN; Mahle CD; Lumb KJ
    J Pharmacol Exp Ther; 2007 Nov; 323(2):692-700. PubMed ID: 17671099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide architecture: adding an alpha-helix to the PYY lysine side chain provides nanomolar binding and body-weight-lowering effects.
    Pedersen SL; Sasikumar PG; Vrang N; Jensen KJ
    ChemMedChem; 2010 Apr; 5(4):545-51. PubMed ID: 20183851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of human serum albumin-modified exendin-4 conjugate via heterobifunctional polyethylene glycol linkage with protracted hypoglycemic efficacy.
    Kim I; Kim TH; Ma K; Lee ES; Kim D; Oh KT; Lee DH; Lee KC; Youn YS
    Bioconjug Chem; 2010 Aug; 21(8):1513-9. PubMed ID: 20715855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FcRn binding properties of an abnormal truncated analbuminemic albumin variant.
    Andersen JT; Daba MB; Sandlie I
    Clin Biochem; 2010 Mar; 43(4-5):367-72. PubMed ID: 20006594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.
    Karacay H; Sharkey RM; Govindan SV; McBride WJ; Goldenberg DM; Hansen HJ; Griffiths GL
    Bioconjug Chem; 1997; 8(4):585-94. PubMed ID: 9258459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A parallel semisynthetic approach for structure-activity relationship studies of peptide YY.
    Albertsen L; Østergaard S; Paulsson JF; Norrild JC; Strømgaard K
    ChemMedChem; 2013 Sep; 8(9):1505-13, 1422. PubMed ID: 23907926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.
    Goumain M; Voisin T; Lorinet AM; Laburthe M
    Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like Peptide 1 Conjugated to Recombinant Human Serum Albumin Variants with Modified Neonatal Fc Receptor Binding Properties. Impact on Molecular Structure and Half-Life.
    Bukrinski JT; Sønderby P; Antunes F; Andersen B; Schmidt EGW; Peters GHJ; Harris P
    Biochemistry; 2017 Sep; 56(36):4860-4870. PubMed ID: 28799326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions.
    Kawakami A; Kubota K; Yamada N; Tagami U; Takehana K; Sonaka I; Suzuki E; Hirayama K
    FEBS J; 2006 Jul; 273(14):3346-57. PubMed ID: 16857017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-acting selective neuropeptide Y2 receptor PEGylated peptide agonist reduces food intake in mice.
    DeCarr LB; Buckholz TM; Milardo LF; Mays MR; Ortiz A; Lumb KJ
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1916-9. PubMed ID: 17292607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.